Fang L - Search Results

1

Assessment of the effect of ofatumumab on cardiac repolarization.

Jewell RC, Laubscher K, Lewis E, Fang L, Gafoor Z, Carey J, McKeown A, West S, Wright O, Sedoti D, Dixon I, Hottenstein CS, Chan G. Jewell RC, et al. Among authors: fang l. J Clin Pharmacol. 2015 Jan;55(1):114-21. doi: 10.1002/jcph.376. Epub 2014 Aug 21. J Clin Pharmacol. 2015. PMID: 25103870 Clinical Trial.

2

An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia.

Patton WN, Lindeman R, Butler AC, Kipps TJ, Jewell RC, Laubscher KH, Zhou YY, Lewis E, Sedoti D, Witman P, Fang L, Chan G. Patton WN, et al. Among authors: fang l. Leuk Lymphoma. 2015;56(10):2819-25. doi: 10.3109/10428194.2015.1014357. Epub 2015 Sep 2. Leuk Lymphoma. 2015. PMID: 25721750 Free PMC article. Clinical Trial.

3

Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy.

Jewell RC, Kipps TJ, Dürig J, Griskevicius L, Stilgenbauer S, Smolej L, Mayer J, Hess G, Hernandez-Ilizaliturri FJ, Padmanabhan-Iyer S, Fang L, Goldstein N, Gorczyca M, Gupta I, Lisby S, Wierda WG; Hx-CD20-407 Study Investigators. Jewell RC, et al. Among authors: fang l. Leuk Lymphoma. 2017 Feb;58(2):348-356. doi: 10.1080/10428194.2016.1195497. Epub 2016 Jul 7. Leuk Lymphoma. 2017. PMID: 27389174 Free PMC article. Clinical Trial.

4

In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc.

Demarest JF, Sparks SS, Schell K, Shibayama S, McDanal CB, Fang L, Adkison KK, Shachoy-Clark A, Piscitelli SC. Demarest JF, et al. Among authors: fang l. J Clin Pharmacol. 2008 Oct;48(10):1179-88. doi: 10.1177/0091270008322178. Epub 2008 Aug 1. J Clin Pharmacol. 2008. PMID: 18676693 Clinical Trial.

5

Integration of modeling and simulation to support changes to ondansetron dosing following a randomized, double-blind, placebo-, and active-controlled thorough QT study.

Zuo P, Haberer LJ, Fang L, Hunt TL, Ridgway D, Russo MW. Zuo P, et al. Among authors: fang l. J Clin Pharmacol. 2014 Nov;54(11):1221-9. doi: 10.1002/jcph.322. Epub 2014 May 6. J Clin Pharmacol. 2014. PMID: 24782199

6

Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours.

Leonowens C, Pendry C, Bauman J, Young GC, Ho M, Henriquez F, Fang L, Morrison RA, Orford K, Ouellet D. Leonowens C, et al. Among authors: fang l. Br J Clin Pharmacol. 2014 Sep;78(3):524-32. doi: 10.1111/bcp.12373. Br J Clin Pharmacol. 2014. PMID: 24606567 Free PMC article. Clinical Trial.

7

Evaluation of the effects of food on the single-dose pharmacokinetics of trametinib, a first-in-class MEK inhibitor, in patients with cancer.

Cox DS, Papadopoulos K, Fang L, Bauman J, LoRusso P, Tolcher A, Patnaik A, Pendry C, Orford K, Ouellet D. Cox DS, et al. Among authors: fang l. J Clin Pharmacol. 2013 Sep;53(9):946-54. doi: 10.1002/jcph.115. Epub 2013 Jul 25. J Clin Pharmacol. 2013. PMID: 23893461 Clinical Trial.

8

Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.

Johnson BM, Song IH, Adkison KK, Borland J, Fang L, Lou Y, Berrey MM, Nafziger AN, Piscitelli SC, Bertino JS Jr. Johnson BM, et al. Among authors: fang l. J Clin Pharmacol. 2006 May;46(5):577-87. doi: 10.1177/0091270006287291. J Clin Pharmacol. 2006. PMID: 16638741 Clinical Trial.

9

The effects of ritonavir and lopinavir/ritonavir on the pharmacokinetics of a novel CCR5 antagonist, aplaviroc, in healthy subjects.

Adkison KK, Shachoy-Clark A, Fang L, Lou Y, Otto VR, Berrey MM, Piscitelli SC. Adkison KK, et al. Among authors: fang l. Br J Clin Pharmacol. 2006 Sep;62(3):336-44. doi: 10.1111/j.1365-2125.2006.02661.x. Br J Clin Pharmacol. 2006. PMID: 16934050 Free PMC article.

10

Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir.

Wire MB, Fang L, Hussaini A, Kleha JF, Theodore D. Wire MB, et al. Among authors: fang l. Antimicrob Agents Chemother. 2014 Nov;58(11):6704-9. doi: 10.1128/AAC.03091-14. Epub 2014 Aug 25. Antimicrob Agents Chemother. 2014. PMID: 25155600 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,437 results

Search Page